Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von GraveDigger 

Affimed N.V. diskutieren

Affimed N.V.

WKN: A12BHU / Symbol: AFMD / Name: Affimed / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

0,55 €
0,09 %

Buy Affimed N.V.

Einschätzung Buy
Rendite (%) -10,95 %
Kursziel 5,58
Veränderung
Endet am 24.03.24

Affimed (NASDAQ: AFMD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Ratings data for AFMD provided by MarketBeat

Affimed (NASDAQ: AFMD) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for AFMD provided by MarketBeat

Einschätzung Buy
Rendite (%) -16,85 %
Kursziel 6,46
Veränderung
Endet am 28.03.24

Affimed (NASDAQ: AFMD) had its "overweight" rating re-affirmed by analysts at Wells Fargo & Company. They now have a $7.00 price target on the stock.
Ratings data for AFMD provided by MarketBeat

Einschätzung Buy
Rendite (%) 9,18 %
Kursziel 4,56
Veränderung
Endet am 11.08.24

Affimed (NASDAQ: AFMD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Ratings data for AFMD provided by MarketBeat

Einschätzung Buy
Rendite (%) 12,95 %
Kursziel 6,54
Veränderung
Endet am 07.09.24

Affimed (NASDAQ: AFMD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $7.00 price target on the stock.
Ratings data for AFMD provided by MarketBeat

Einschätzung Buy
Rendite (%) 23,49 %
Kursziel 6,61
Veränderung
Endet am 25.09.24

Affimed (NASDAQ: AFMD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $7.00 price target on the stock.
Ratings data for AFMD provided by MarketBeat

Affimed (NASDAQ: AFMD) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AFMD provided by MarketBeat

Affimed (NASDAQ: AFMD) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AFMD provided by MarketBeat

Affimed (NASDAQ: AFMD) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AFMD provided by MarketBeat

Einschätzung Buy
Rendite (%) 73,68 %
Kursziel 4,61
Veränderung
Endet am 15.11.24

Affimed (NASDAQ: AFMD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Ratings data for AFMD provided by MarketBeat

Affimed (NASDAQ: AFMD) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AFMD provided by MarketBeat

Affimed (NASDAQ: AFMD) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AFMD provided by MarketBeat

Affimed (NASDAQ: AFMD) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AFMD provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 9,27
Veränderung
Endet am 01.04.25

Affimed (NASDAQ: AFMD) had its price target raised by analysts at HC Wainwright to $10.00. They now have a "buy" rating on the stock.
Ratings data for AFMD provided by MarketBeat

Affimed (NASDAQ: AFMD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for AFMD provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 23,28
Veränderung
Endet am 01.04.25

Affimed (NASDAQ: AFMD) had its price target lowered by analysts at Wells Fargo & Company from $30.00 to $25.00. They now have an "overweight" rating on the stock.
Ratings data for AFMD provided by MarketBeat